Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.524 USD | +0.38% | +2.16% | -2.63% |
Mar. 22 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
Mar. 14 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
Financials (USD)
Sales 2024 * | 36.94M | Sales 2025 * | 64.14M | Capitalization | 108M |
---|---|---|---|---|---|
Net income 2024 * | -109M | Net income 2025 * | -82M | EV / Sales 2024 * | 4.04 x |
Net Debt 2024 * | 40.79M | Net Debt 2025 * | 129M | EV / Sales 2025 * | 3.7 x |
P/E ratio 2024 * |
-1.05
x | P/E ratio 2025 * |
-1.69
x | Employees | 405 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.29% |
Latest transcript on Sangamo Therapeutics, Inc.
1 day | -4.01% | ||
1 week | +3.78% | ||
Current month | +1.38% | ||
1 month | -10.22% | ||
3 months | +6.18% | ||
6 months | +13.48% | ||
Current year | -3.92% |
Managers | Title | Age | Since |
---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 61 | 16-05-31 |
Director of Finance/CFO | 46 | 19-02-28 | |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peg Horn
BRD | Director/Board Member | 61 | 22-12-14 |
James Meyers
BRD | Director/Board Member | 59 | 19-11-21 |
H. Parker
CHM | Chairman | 68 | 14-06-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.66% | 2 M€ | -25.75% | ||
0.49% | 16 M€ | -4.51% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.525 | +0.57% | 460 235 |
24-05-02 | 0.522 | -4.01% | 853,148 |
24-05-01 | 0.5438 | +5.61% | 1,320,615 |
24-04-30 | 0.5149 | -1.42% | 833,768 |
24-04-29 | 0.5223 | +0.87% | 968,787 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.92% | 108M | |
-1.65% | 103B | |
+6.75% | 101B | |
+6.67% | 23.07B | |
-12.60% | 22.23B | |
-4.64% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- SGMO Stock